Driving impact across research, commercialization, and care
Since 2010, OBI has worked to position Ontario as a global leader in brain health. By aligning the strengths of researchers, innovators, clinicians, and community partners, we foster collaboration that leads to meaningful improvements in care, policy, and commercialization.
Our impact is measured not just in discoveries, but in how we empower our partners to deliver better outcomes for people living with brain disorders.
OBI leveraged an initial $2 million gift into a $700 million impact on brain health. And with one in three individuals affected by a brain disorder, OBI is proud to have reached over one million people through our programs and initiatives.
Impact at a Glance
- 8K+
patients supported
- 25+
brain health products to market
- 50+
clinical trials
- 180+
interns with over 80% follow-on employment
- 1,000
scientific publications
- 8K+
highly qualified personnel trained
- 27x
return on investment from portfolio companies
- 950+
researchers using Brain-CODE
- 27K
patient participants with health data on Brain-CODE
Bringing Lab to Life. Together.
We recently put ourselves and our team science approach to the test, and asked the researchers, companies, and community organizations we work with if we are indeed having a positive impact on the resources and abilities they need to achieve their goals.
- advance research through team science,
- invest in home-grown neurotech, and
- support person-centred research and care in communities.
We invite you to see how we have worked together with our partners to bring lab to life.
The difference a year makes: Inspired by the Government of Ontario’s re-investment in the Ontario Brain Institute, we asked some of our patient and community partners about their hope for the future of brain health. Here is what they had to say about OBI.